Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 126.73%25.26M | 67.44%12.77M | 8.00%9.49M | 62.86%38.39M | 66.75%10.84M | 54.97%11.14M | 9.64%7.63M | 200.17%8.78M | 23.57M | 6.5M |
| Cost of revenue | 79.05%9.34M | 115.65%5.24M | 23.30%3.72M | 96.95%14.51M | 79.76%3.85M | 113.94%5.22M | 23.25%2.43M | 269.24%3.01M | 7.37M | 2.14M |
| Gross profit | 168.72%15.92M | 44.93%7.54M | 0.02%5.77M | 47.36%23.88M | 60.35%6.99M | 24.69%5.92M | 4.27%5.2M | 173.46%5.77M | 16.21M | 4.36M |
| Operating expense | 127.57%10.16M | 48.27%6.36M | 13.77%4.34M | 32.17%17.11M | 16.62%4.6M | 12.10%4.47M | 24.56%4.29M | 144.99%3.81M | 963.95%12.95M | 900.88%3.94M |
| Selling and administrative expenses | 127.87%9.77M | 46.69%6.03M | 13.77%4.34M | 32.17%17.11M | 16.62%4.6M | 7.63%4.29M | 19.38%4.11M | 144.99%3.81M | 963.95%12.95M | 900.88%3.94M |
| -General and administrative expense | 127.87%9.77M | 46.69%6.03M | 13.77%4.34M | 32.17%17.11M | 16.62%4.6M | 7.63%4.29M | 19.38%4.11M | 144.99%3.81M | 963.95%12.95M | 900.88%3.94M |
| Depreciation and amortization | 120.22%392K | 84.83%329K | ---- | ---- | ---- | --178K | --178K | ---- | ---- | ---- |
| -Depreciation | 120.22%392K | 84.83%329K | ---- | ---- | ---- | --178K | --178K | ---- | ---- | ---- |
| Operating profit | 294.65%5.76M | 29.29%1.18M | -26.76%1.43M | 107.67%6.77M | 475.66%2.39M | 89.97%1.46M | -40.85%915K | 253.43%1.96M | 367.90%3.26M | 205.40%415K |
| Net non-operating interest income (expenses) | -1,971.43%-393K | -735.48%-197K | -200.00%-31K | -825.27%-68.32K | -144.00%-22K | -36.36%21K | 121.43%31K | 306.67%31K | -7.38K | 516.67%50K |
| Non-operating interest income | -20.00%20K | -63.89%13K | -41.67%21K | 43.33%129K | -36.00%32K | -34.21%25K | 157.14%36K | 620.00%36K | --90K | --50K |
| Non-operating interest expense | 10,225.00%413K | 4,100.00%210K | 940.00%52K | 825.27%68.32K | --54K | -20.00%4K | --5K | -75.00%5K | --7.38K | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 1,144.32%1.1M | 200.00%90K | 293.75%126K | 1,682.65%322.48K | 855.56%172K | 88K | 30K | 32K | 18.09K | 18K |
| Special income (charges) | -135.55%-18.11K | 50.94K | ||||||||
| Less:Write off | ---- | ---- | ---- | 135.55%18.11K | ---- | ---- | ---- | ---- | ---50.94K | ---- |
| Other non-operating income (expenses) | -104.94%-8K | 489.75%1.44M | 236.71%266K | 139.61%619.26K | 775.00%35K | 3,950.00%162K | 6,000.00%244K | -57.07%79K | 1,442.77%258.45K | 4K |
| Income before tax | 272.95%6.45M | 106.15%2.52M | -14.52%1.8M | 113.00%7.62M | 428.54%2.57M | 114.91%1.73M | -22.04%1.22M | 190.46%2.1M | 398.31%3.58M | 225.19%487K |
| Income tax | 104.62%1.06M | 37.55%707K | -21.20%461K | 55.24%2.36M | 96.02%739K | 103.92%520K | -24.96%514K | 188.18%585K | 1.52M | 18,950.00%377K |
| Net income | 345.29%5.39M | 156.09%1.81M | -11.95%1.33M | 155.58%5.27M | 1,568.18%1.84M | 120.00%1.21M | -19.77%706K | 191.35%1.52M | 271.70%2.06M | 128.42%110K |
| Net income continuous operations | 345.29%5.39M | 156.09%1.81M | -11.95%1.33M | 155.58%5.27M | 1,568.18%1.84M | 120.00%1.21M | -19.77%706K | 191.35%1.52M | 271.70%2.06M | 128.42%110K |
| Noncontrolling interests | 14,355.56%2.57M | 4,250.00%83K | -83.67%8K | -88.37%69.43K | 344.44%40K | -108.04%-18K | -100.82%-2K | -59.50%49K | 596.83K | 9K |
| Net income attributable to the company | 129.80%2.82M | 143.64%1.73M | -9.55%1.33M | 255.06%5.2M | 1,677.23%1.8M | 276.69%1.23M | 11.15%708K | 267.42%1.47M | 221.97%1.46M | 126.10%101K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 129.80%2.82M | 143.64%1.73M | -9.55%1.33M | 255.06%5.2M | 1,677.23%1.8M | 276.69%1.23M | 11.15%708K | 267.42%1.47M | 221.97%1.46M | 126.10%101K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 123.39%0.0102 | 137.04%0.6217 | -12.50%0.0048 | 164.28%0.0144 | 1,173.52%0.005 | 422.43%0.0046 | 9,542.87%0.2623 | 211.03%0.0054 | 162.92%0.0054 | 113.81%0.0004 |
| Diluted earnings per share | 123.39%0.0102 | 137.04%0.6217 | -12.50%0.0048 | 164.28%0.0144 | 1,173.52%0.005 | 422.43%0.0046 | 9,542.87%0.2623 | 211.03%0.0054 | 162.92%0.0054 | 113.81%0.0004 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.